Mizuho raises Lam Research stock price target on WFE outlook By Investing.com

Lam Research beat fiscal Q3 expectations with EPS of $1.47 versus $1.35 consensus and revenue of $5.84 billion versus $5.73 billion. Management also issued strong June quarter guidance, with revenue projected at $6.6 billion above the $6.05 billion consensus, while raising the 2026 wafer fabrication equipment outlook to about $140 billion, up 27% year over year. Mizuho lifted its price target to $330 from $295 and now sees 2026 revenue growth above 30%, reinforcing a constructive near-term outlook for LRCX.

Analysis

The key read-through is that Lam’s guide raise is less about a one-quarter beat and more about a duration extension of the semi capex cycle. When tool spend is being pulled forward rather than merely re-rated, the incremental winners are the vendors with the highest exposure to advanced DRAM, GAA/foundry complexity, and advanced packaging; that usually narrows leadership to a small set of process-critical names while commoditized equipment names lag. The market should also start pricing a more durable mix shift: if HBM, advanced packaging, and 200-layer NAND conversion are all accelerating together, service attach rates and consumables become a bigger part of the bull case than new-tool shipments alone.

The second-order effect is on competitive positioning, not just industry revenue. A higher addressable market share target implies Lam is likely taking share in the most technically demanding nodes, which tends to pressure smaller etch/deposition peers that lack comparable process breadth and installed-base leverage. If this spend wave persists into 2026-2027, foundry and memory customers may prioritize supplier consolidation for yield risk reduction, which can widen the gap between the top-tier equipment platforms and everyone else.

The main risk is not demand, but multiple compression: a stock already near highs can keep rising operationally while underperforming if investors conclude the growth acceleration is already fully discounted. The more immediate catalyst window is the next two quarters, where guidance credibility matters more than long-term TAM slides; any digestion in June-quarter upside or a pause in capex cadence would likely hit the stock faster than the broader semi group. Over a longer horizon, the bull case weakens only if HBM intensity normalizes sooner than expected or if NAND conversion spending slips out again, which would push the revenue inflection one to two years farther out.

Contrarianly, the consensus may be underestimating how much of this is a quality-of-revenue story rather than pure top-line growth. If the market treats this as a broad semi beta trade, it misses that Lam is tied to the parts of the cycle with the highest pricing power and least substitution risk. That said, after a 12-month run of this magnitude, upside from here is likely more about estimate revision and peer-relative multiple expansion than heroic rerating.

Key Decisions for Investors

• Stay long LRCX on pullbacks over the next 1-3 weeks; use dips toward the prior breakout zone for entries, targeting another 10-15% upside if 2026 consensus keeps moving higher, with a tighter stop if estimates stop rising.
• Pair trade: long LRCX / short a lower-quality semi-capex name with weaker foundry-memory exposure over the next 1-2 months; the thesis is that share gains and service leverage should outperform broad toolmaker beta by 5-8 points.
• Buy 3-6 month LRCX call spreads rather than outright stock if implied volatility stays elevated; this captures estimate momentum while defining risk if the market decides the good news is already priced.
• Take profits selectively on any LRCX spike into fresh highs; the stock is entering a zone where operational upside can coexist with valuation compression, limiting standalone multiple expansion.